the drugs enhanced hdl receptor activity , dependent on apo-e and -a1 , and hdl degradation in the hepatocytes , whereas in fibroblasts and aorta cells hdl receptor binding and degradation were suppressed .
C0016030
fibroblasts
C0007634
cells